Độ an toàn lâu dài của bệnh nhân nhận rituximab trong các thử nghiệm lâm sàng viêm khớp dạng thấp

Genovese, 2005, Longterm safety, efficacy, and radiographic outcome with etanercept treatment in patients with early rheumatoid arthritis, J Rheumatol, 32, 1232

10.1002/art.20159

10.1136/ard.2005.043166

10.1016/j.semarthrit.2008.01.001

10.1001/jama.295.19.2275

10.1093/rheumatology/keg263

10.1002/art.21675

10.1016/j.amjmed.2003.09.039

10.1016/0049-0172(78)90008-2

Maloney, 1997, IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin’s lymphoma, Blood, 90, 2188, 10.1182/blood.V90.6.2188

10.1002/art.22025

10.1002/art.21778

10.1002/art.23059

Sell S Max EE . All about B cells. In: Immunology, immunopathology, and immunity. Herndon, VA: ASM Press; 2001:101.

10.1056/NEJMoa032534

Emery P Rigby WF Combe B Latinis K Szczepanski LJ Roschmann RA Efficacy and safety of rituximab (RTX) as first line biologic therapy in patients with active rheumatoid arthritis. Results of a phase III randomized, controlled study (SERENE) [abstract]. Arthritis Rheum 2008;Suppl 58:S302.

Rubbert-Roth A Tak PP Bombardieri S Zerbini C Tremblay J Carreño L Efficacy and safety of various dosing regimens of rituximab in patients with active RA: results of a phase III randomized study (MIRROR) [abstract]. Arthritis Rheum 2008;Suppl 58:S301.

Mease PJ Cohen S Gaylis NB Chubick A Kaell AT Greenwald M Efficacy, safety, and dose frequency of retreatment with rituximab in RA: results from a randomized controlled trial (SUNRISE) [abstract]. Arthritis Rheum 2008;Suppl 58:S619.

Bingham C Looney R Deodhar A Halsey N Greenwald M Codding C Results from a controlled clinical trial (SIERRA) to evaluate primary and recall responses to immunizations in RA patients treated with rituximab [abstract]. Arthritis Rheum 2008;Suppl 58:S900.

Keystone EC Fleischmann R Emery P Chubick A Dougados MR Baldassare AR Efficacy and safety of repeat treatment courses of rituximab (RTX) in RA patients with inadequate response to tumor necrosis factor inhibitors; long-term experience from the REFLEX study [abstract]. Arthritis Rheum 2008;Suppl 58:S303.

Centers for Disease Control/National Center for Health Statistics . National Vital Statistics Reports. Deaths: Final data for 2005. [Internet. Accessed Dec 10, 2009.] Available from: http://www.cdc.gov/nchs/data/nvsr/nvsr56/nvsr56_10.pdf

Moreland, 2006, Etanercept treatment in adults with established rheumatoid arthritis: 7 years of clinical experience, J Rheumatol, 33, 854

10.1136/ard.2007.074773

10.1002/art.23397

10.1093/rheumatology/kel328

10.1002/art.23112

10.1007/s11940-008-0019-8

10.1001/archneur.65.11.1538

10.1016/j.autrev.2008.07.006

10.1002/art.22967

Bonilla, 2005, Practice parameter for the diagnosis and management of primary immunodeficiency, Ann Allergy Asthma Immunol, 94, S1, 10.1016/S1081-1206(10)61142-8

10.1056/NEJMoa0706383

10.1002/ana.21363

10.1093/geronj/48.6.B231

10.1002/art.22809

10.1136/ard.2005.050377

10.1016/0959-8049(96)00210-9

10.1002/art.22579

10.1186/ar2404

10.1136/ard.2006.066761